Sera Prognostics (SERA) Net Margin Growth (1y) (2021 - 2026)
Sera Prognostics (SERA) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 656.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -430.00 |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 201.00 |
| 10 | Sera Prognostics | 103.03 Mn | 103.03 Mn | -28,000.00 | -5.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.52 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | -5.05 Mn |
| Jun 30, 2025 | -3.64 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | -995,394.00 |
| Jun 30, 2024 | -2.71 Mn |
| Dec 31, 2023 | -224,949.00 |
| Sep 30, 2023 | -575,181.00 |
| Jun 30, 2023 | 592,411.00 |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 3.01 Mn |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | 4.03 Mn |
| Sep 30, 2021 | 5.84 Mn |
| Jun 30, 2021 | 4.14 Mn |